GHRP-2 and GHRP-6 are two of the oldest growth hormone-releasing peptides. They are often compared online as if picking one were a simple matter of taste. The real story is that both are unapproved, both have limited human data, and they differ in a few important ways.
Key takeaways
- GHRP-2 and GHRP-6 are short, lab-made peptides that act on the ghrelin receptor to trigger growth hormone (GH) release.
- GHRP-6 is known for a strong hunger effect. GHRP-2 is generally described as a stronger GH releaser that can also raise cortisol and prolactin.
- Neither is FDA-approved in the US.
- FDA has flagged both with safety concerns for compounding, including possible blood sugar effects.
- Both are banned at all times under the 2026 WADA Prohibited List.
Where GHRPs came from
GHRPs (growth hormone-releasing peptides) were designed in the 1980s and 1990s, before scientists discovered ghrelin. Researchers found that certain small peptides caused a big GH release, and only later learned that they work through the same receptor that ghrelin uses. That receptor is called the growth hormone secretagogue receptor.
GHRP-6 came first. GHRP-2 and hexarelin followed as attempts to improve potency. Later, ipamorelin was designed to be more selective. Our beginner's guide to GH secretagogues covers how these fit with GHRH analogs like tesamorelin.
How they work
When a GHRP binds the ghrelin receptor in the pituitary and hypothalamus, it triggers a pulse of GH. GH then raises IGF-1. Because ghrelin is also a hunger hormone, these peptides can increase appetite. Some also nudge other hormones, such as cortisol (a stress hormone) and prolactin.
GHRP-2 vs. GHRP-6 at a glance
| GHRP-2 | GHRP-6 | |
|---|---|---|
| Also called | Pralmorelin | (none common) |
| Receptor | Ghrelin receptor | Ghrelin receptor |
| GH release in research | Generally described as stronger | Strong, often described as less than GHRP-2 |
| Appetite effect | Present | Known for being pronounced |
| Cortisol and prolactin | Can rise | Can rise; FDA notes cortisol effects |
| FDA-approved in US? | No | No |
| FDA compounding notes | Immunogenicity, impurities, serious adverse event reports | Immunogenicity, cortisol and blood sugar concerns |
| WADA 2026 | Prohibited | Prohibited |
These comparisons come from older, mostly small studies and from FDA's summary. They describe general patterns, not what will happen in any one person.
What the research shows
Most human research on GHRPs comes from the 1990s and 2000s. Studies showed that both peptides reliably raise GH in the short term, and researchers explored them as tools to test pituitary function and in a few medical settings. A 2018 review of GH secretagogues found that this class can raise GH and IGF-1, increase appetite and in some studies change body composition. It also noted that studies were mostly small and short, with few long-term controlled trials.
For GHRP-2 and GHRP-6 specifically, there are no large modern trials showing benefits for muscle, fat loss, recovery or aging in healthy adults.
What FDA has said
FDA keeps a list of bulk substances that "may present significant safety risks" when used in compounding. Both peptides are listed in Category 2 for 503B outsourcing facilities.
- GHRP-2: FDA cited possible immunogenicity and impurity concerns. It noted reports of serious adverse events, including increased insulin needs, death in critically ill study subjects, infection and pancreatitis, while stating that cause was not established.
- GHRP-6: FDA cited possible immunogenicity and, despite limited safety data, concerns about effects on cortisol and higher blood glucose from reduced insulin sensitivity.
On FDA's separate list of substances nominated for 503A compounding, both are in Category 3, meaning they were nominated without adequate support. If you see these sold as "research chemicals," they are not made for human use. See our post on research-use-only peptides.
Side effects to know about
Reported or expected effects across GHRPs include:
- Increased hunger, strongest with GHRP-6
- Higher blood sugar and lower insulin sensitivity
- Water retention, swelling, tingling or joint aches
- Raised cortisol or prolactin
- Flushing and injection site reactions
- Unknown long-term effects, including on tumor growth, since GH and IGF-1 drive cell growth
People with diabetes or prediabetes, a history of cancer, heart disease or pituitary problems, or who are pregnant face extra risks and should not experiment with these.
So which is "better"?
Neither is a medically supported choice for healthy adults. Online comparisons often treat GHRP-2 as the "lean" option and GHRP-6 as the "bulking" option because of the hunger effect. Those labels come from forums, not clinical trials. Both raise GH, both can affect blood sugar, and both lack long-term safety data.
If your real goal is better body composition, the best-supported tools are still protein, strength training, sleep and, when appropriate, an FDA-approved treatment chosen with a provider. Our telehealth guide explains how to find a licensed one.
The bottom line
GHRP-2 and GHRP-6 work through the same receptor and differ mainly in hunger and side-hormone effects. Both are unapproved, flagged by FDA for safety concerns and banned in sport. If growth hormone is on your mind, a lab test and a conversation with a licensed provider are a better first step than choosing between the two.
Sources
- FDA: Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
- FDA: Bulk Drug Substances Nominated for Use in Compounding Under Section 503A
- Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues. Sex Med Rev. 2018
- World Anti-Doping Agency: The Prohibited List (2026)
Frequently asked questions
What is the main difference between GHRP-2 and GHRP-6?
Both act on the ghrelin receptor to raise growth hormone. Research and FDA notes describe GHRP-6 as having a stronger appetite effect, while GHRP-2 is generally described as a stronger GH releaser that can also raise cortisol and prolactin. Neither is FDA-approved.
Are GHRP-2 and GHRP-6 legal to use?
Neither is an FDA-approved drug in the US, and FDA has listed both among substances that raise significant safety concerns for compounding by outsourcing facilities. Both are also banned in sport under the WADA Prohibited List.
Why would increased appetite matter?
For someone trying to manage weight or blood sugar, a strong hunger signal can work against their goals. It is one reason these peptides are not a simple fit for most people and should not be used without a licensed provider's guidance.